
Ablative Solutions
A medical device firm that offers an alternative to surgical renal denervation for treating hypertension.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
* | N/A | $29.3m | Convertible |
Total Funding | 000k |
Related Content
Ablative Solutions, Inc. focuses on developing innovative medical devices aimed at reducing high blood pressure, specifically targeting patients with uncontrolled hypertension. The company's core product, the Peregrine System Kit, is currently under investigation to evaluate its safety and effectiveness in clinical trials. Ablative Solutions operates in the medical device market, serving healthcare providers and patients who struggle with hypertension that is resistant to conventional treatments. The business model revolves around the development, clinical testing, and eventual commercialization of their proprietary medical devices. Revenue is anticipated to be generated through the sale of these devices to hospitals, clinics, and healthcare providers once regulatory approvals are obtained.
Keywords: hypertension, medical devices, Peregrine System Kit, clinical trials, investigational product, high blood pressure, healthcare, innovation, safety, effectiveness.